|
|
Volumn 19, Issue 4, 2008, Pages 287-295
|
|
Apoptosis, airway inflammation and anti-asthma therapy: From immunobiology to clinical application
|
|
Author keywords
Airway inflammation; Apoptosis; Asthma
|
|
Indexed keywords
ANTIASTHMATIC AGENT;
BECLOMETASONE;
BLEOMYCIN;
DEFLAZACORT;
DEXAMETHASONE;
FAS ANTIBODY;
FLUTICASONE;
GAMMA INTERFERON;
IMMUNOGLOBULIN E;
INTERLEUKIN 2;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
MEPOLIZUMAB;
MONTELUKAST;
OMALIZUMAB;
PROTEIN BCL 2;
RECOMBINANT INTERLEUKIN 12;
RESLIZUMAB;
SALMETEROL;
STEROID;
THEOPHYLLINE;
TRANSFORMING GROWTH FACTOR BETA;
TUMOR NECROSIS FACTOR;
ALLERGIC ASTHMA;
ALLERGIC REACTION;
APOPTOSIS;
CLINICAL TRIAL;
DRUG MECHANISM;
DRUG POTENTIATION;
FIBROSIS;
HOMEOSTASIS;
HUMAN;
IMMUNE SYSTEM;
IMMUNOBIOLOGY;
INTERSTITIAL LUNG DISEASE;
LUNG LAVAGE;
NONHUMAN;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RESPIRATORY TRACT INFLAMMATION;
REVIEW;
T LYMPHOCYTE;
TH2 CELL;
ANIMALS;
ANTI-ASTHMATIC AGENTS;
APOPTOSIS;
ASTHMA;
BRONCHIAL HYPERREACTIVITY;
CYTOKINES;
FIBROSIS;
HUMANS;
IMMUNOGLOBULINS;
IMMUNOTHERAPY;
TH1 CELLS;
TH2 CELLS;
|
|
EID: 43749098565
PISSN: 09056157
EISSN: 13993038
Source Type: Journal
DOI: 10.1111/j.1399-3038.2007.00668.x Document Type: Review |
|
Times cited : (19)
|
|
References (81)
|
